Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Franck

Showing results (61-70 of 125) with videos related to

Pageof 13
Sort By:
Nordic Journal of Psychiatry|March 13, 2019
Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot studyMichel Arvidsson, Marja-Liisa Dahl, Johan Franck, et al.
Addiction (Abingdon, England)|January 25, 2026
Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high-resolution electronic health recordsDanilo Romero, Martin Kåberg, Anne H Berman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 25, 2007
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependenceNitya Jayaram-Lindström, Maija Konstenius, Staffan Eksborg, et al.
Journal of Epidemiology and Community Health|May 21, 2024
Excess mortality among people in homelessness with substance use disorders: a Swedish cohort studySophie Nadia Gaber, Johan Franck, Härje Widing, et al.
BMC Psychiatry|July 24, 2023
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorderChristoffer Brynte, Lotfi Khemiri, Hannes Stenström, et al.
Dermatology (Basel, Switzerland)|April 1, 2015
Alcohol intake measured by phosphatidylethanol in blood and the lifetime drinking history interview are correlated with the extent of psoriasisLinnea Zou, Sol-Britt Lonne-Rahm, Anders Helander, et al.
Drug and Alcohol Dependence|August 25, 2022
Gender specific early treatment for women with alcohol addiction (EWA): Impact on work related outcomes. A 25-year registry follow-up of a randomized controlled trial (RCT)Line Iden Berge, Rolf Gjestad, Johan Franck, et al.
The Pharmacogenomics Journal|October 23, 2022
Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorderValentin Skryabin, Ilya Rozochkin, Mikhail Zastrozhin, et al.
Biological Psychiatry|July 24, 2012
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbensPia Steensland, Ida Fredriksson, Sarah Holst, et al.
Brain Research|October 6, 2009
The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphinAnders Hammarberg, Ingrid Nylander, Qin Zhou, et al.
Pageof 13

Showing results (61-70 of 125) with videos related to

Sort By:
Pageof 13
Nordic Journal of Psychiatry|March 13, 2019
Methylphenidate effects on processing speed in a clinical sample of adults with ADHD and substance use disorder: a pilot studyMichel Arvidsson, Marja-Liisa Dahl, Johan Franck, et al.
Addiction (Abingdon, England)|January 25, 2026
Predictors of outpatient treatment engagement following a visit to a specialized emergency department for substance use: A cohort study using high-resolution electronic health recordsDanilo Romero, Martin Kåberg, Anne H Berman, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 25, 2007
Naltrexone attenuates the subjective effects of amphetamine in patients with amphetamine dependenceNitya Jayaram-Lindström, Maija Konstenius, Staffan Eksborg, et al.
Journal of Epidemiology and Community Health|May 21, 2024
Excess mortality among people in homelessness with substance use disorders: a Swedish cohort studySophie Nadia Gaber, Johan Franck, Härje Widing, et al.
BMC Psychiatry|July 24, 2023
Impulsive choice in individuals with comorbid amphetamine use disorder and attention deficit-hyperactivity disorderChristoffer Brynte, Lotfi Khemiri, Hannes Stenström, et al.
Dermatology (Basel, Switzerland)|April 1, 2015
Alcohol intake measured by phosphatidylethanol in blood and the lifetime drinking history interview are correlated with the extent of psoriasisLinnea Zou, Sol-Britt Lonne-Rahm, Anders Helander, et al.
Drug and Alcohol Dependence|August 25, 2022
Gender specific early treatment for women with alcohol addiction (EWA): Impact on work related outcomes. A 25-year registry follow-up of a randomized controlled trial (RCT)Line Iden Berge, Rolf Gjestad, Johan Franck, et al.
The Pharmacogenomics Journal|October 23, 2022
Meta-analysis of pharmacogenetic clinical decision support systems for the treatment of major depressive disorderValentin Skryabin, Ilya Rozochkin, Mikhail Zastrozhin, et al.
Biological Psychiatry|July 24, 2012
The monoamine stabilizer (-)-OSU6162 attenuates voluntary ethanol intake and ethanol-induced dopamine output in nucleus accumbensPia Steensland, Ida Fredriksson, Sarah Holst, et al.
Brain Research|October 6, 2009
The effect of acamprosate on alcohol craving and correlation with hypothalamic pituitary adrenal (HPA) axis hormones and beta-endorphinAnders Hammarberg, Ingrid Nylander, Qin Zhou, et al.
Pageof 13